SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Wilmington Trust Corp, et al. – ‘SC 13G/A’ on 2/14/07 re: West Pharmaceutical Services Inc

On:  Wednesday, 2/14/07, at 4:09pm ET   ·   Accession #:  893220-7-359   ·   File #:  5-17487

Previous ‘SC 13G’:  ‘SC 13G/A’ on 2/14/07   ·   Next:  ‘SC 13G’ on 2/14/07   ·   Latest:  ‘SC 13G/A’ on 2/14/11

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/14/07  Wilmington Trust Corp             SC 13G/A               1:13K  West Pharmaceutical Services Inc  Bowne - Bop/FA
          Wilmington Trust Company
          Wilmington Trust Corporation
          Wilmington Trust FSB

Amendment to Statement of Beneficial Ownership   —   Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G/A    Schedule 13G (Rule 13D-102)                            7     27K 


Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
5Item 1(A). Name of Issuer:
"Item 1(B). Address of Issuer's Principal Executive Offices:
"Item 2(A). Name of Person Filing:
"Item 2(B). Address of Principal Business Office, or If None, Residence:
"Item 2(C). Citizenship:
"Item 2(D). Title of Class of Securities:
"Item 2(E). Cusip Number: 955306-105
"Item 3. If This Statement Is Filed Pursuant to Rule 13D-1(B), or 13D-2(B) or (C), Check Whether the Person Filing Is A:
6Item 4. Ownership
"Item 5. Ownership of Five Percent or Less of A Class
"Item 6. Ownership of More Than Five Percent on Behalf of Another Person
"Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
"Item 8. Identification and Classification of Members of the Group
7Item 9. Notice of Dissolution of Group
"Item 10. Certifications
SC 13G/A1st Page of 7TOCTopPreviousNextBottomJust 1st
 

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) Amendment No. 5 Exit Filing West Pharmaceuticals Services, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 955306-105 (CUSIP Number) December 31, 2006 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-(c) [ ] Rule 13d-1(d)
SC 13G/A2nd Page of 7TOC1stPreviousNextBottomJust 2nd
CUSIP No. 943315-101 -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Wilmington Trust Corporation, 51-0328154 -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] -------------------------------------------------------------------------------- 3. SEC USE ONLY -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware corporation -------------------------------------------------------------------------------- 5. SOLE VOTING POWER: 365,264 NUMBER OF ----------------------------------------------------------------- SHARES 6. SHARED VOTING POWER: BENEFICIALLY OWNED BY 0 EACH ----------------------------------------------------------------- REPORTING 7. SOLE DISPOSITIVE POWER: PERSON WITH: 0 ----------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER: 277,466 -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 642,730 -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] N/A -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.9% -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON HC --------------------------------------------------------------------------------
SC 13G/A3rd Page of 7TOC1stPreviousNextBottomJust 3rd
CUSIP No. 955306-105 -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Wilmington Trust Company, solely in its capacity as fiduciary 51-0055023 -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] -------------------------------------------------------------------------------- 3. SEC USE ONLY ------------------------------------------------------------------------------ 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware banking corporation -------------------------------------------------------------------------------- 5. SOLE VOTING POWER: 365,264 NUMBER OF ----------------------------------------------------------------- SHARES 6. SHARED VOTING POWER: BENEFICIALLY OWNED BY 0 EACH ----------------------------------------------------------------- REPORTING 7. SOLE DISPOSITIVE POWER: PERSON WITH: 0 ----------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER: 267,670 -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 632,934 -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] N/A -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.9% -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* BK --------------------------------------------------------------------------------
SC 13G/A4th Page of 7TOC1stPreviousNextBottomJust 4th
CUSIP No. 955306-105 -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Wilmington Trust FSB, solely in its fiduciary capacity 52-1877389 -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] -------------------------------------------------------------------------------- 3. SEC USE ONLY -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Federal Savings Bank -------------------------------------------------------------------------------- 5. SOLE VOTING POWER: 0 NUMBER OF ----------------------------------------------------------------- SHARES 6. SHARED VOTING POWER: BENEFICIALLY OWNED BY 0 EACH ----------------------------------------------------------------- REPORTING 7. SOLE DISPOSITIVE POWER: PERSON WITH: 0 ----------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER: 9,796 -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9,796 -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] N/A -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0% -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* BK --------------------------------------------------------------------------------
SC 13G/A5th Page of 7TOC1stPreviousNextBottomJust 5th
ITEM 1(A). NAME OF ISSUER: West Pharmaceuticals Services, Inc. ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 101 Gordon Drive Lionville, PA 19341 ITEM 2(A). NAME OF PERSON FILING: Wilmington Trust Corporation, Wilmington Trust Company, Wilmington Trust FSB ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR IF NONE, RESIDENCE: 1100 North Market Street Wilmington, DE 19890 ITEM 2(C). CITIZENSHIP: Wilmington Trust Corporation is a Delaware corporation; Wilmington Trust Company is a Delaware banking corporation. Wilmington Trust FSB is a Federal Savings Bank ITEM 2(D). TITLE OF CLASS OF SECURITIES: Common Stock ITEM 2(E). CUSIP NUMBER: 955306-105 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Exchange Act. (b) [X] Bank as defined in Section 3(a)(6) of the Exchange Act. Wilmington Trust Company and Wilmington Trust FSB are each Banks and are each direct, wholly-owned subsidiaries of Wilmington Trust Corporation. (c) [ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [ ] Investment company registered under Section 8 of the Investment Company Act. (e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); Wilmington Trust Corporation is a Parent Holding Company. (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
SC 13G/A6th Page of 7TOC1stPreviousNextBottomJust 6th
(i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [X] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). Wilmington Trust Corporation, Wilmington Trust Company and Wilmington Trust FSB are a Group. ITEM 4. OWNERSHIP. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: Wilmington Trust Corporation: 642,730 shares Wilmington Trust Company: 632,934 shares Wilmington Trust FSB: 9,796 shares (b) Percent of class: Wilmington Trust Corporation: 1.9% Wilmington Trust Company: 1.9% Wilmington Trust FSB: 0.0% (c) Number of shares as to which Wilmington Trust Corporation, Wilmington Trust Company and Wilmington Trust FSB have: (i) Sole power to vote or to direct the vote 365,264 shares (ii) Shared power to vote or to direct the vote shares 0 (iii) Sole power to dispose or to direct the disposition of 0 shares (iv) Shared power to dispose or to direct the disposition of 277,466 shares ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X] ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Wilmington Trust Company: BK Wilmington Trust FSB: BK ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Wilmington Trust Corporation: HC Wilmington Trust Company: BK Wilmington Trust FSB: BK
SC 13G/ALast Page of 7TOC1stPreviousNextBottomJust 7th
ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable. ITEM 10. CERTIFICATIONS. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 13, 2007 WILMINGTON TRUST CORPORATION WILMINGTON TRUST COMPANY WILMINGTON TRUST FSB By: /s/ Michael A. DiGregorio ------------------------------------ Michael A. DiGregorio Senior Vice President Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties for whom copies are to be sent. Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18U.S.C.1001).

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘SC 13G/A’ Filing    Date First  Last      Other Filings
Filed on:2/14/0713F-NT/A,  SC 13G,  SC 13G/A
2/13/0774,  8-K
12/31/06110-K,  11-K,  11-K/A,  13F-NT/A,  8-K
 List all Filings 
Top
Filing Submission 0000893220-07-000359   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 6, 7:44:03.2am ET